MedTrace Logo

Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors

NCT05631002 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-11-30

No results posted yet for this study

Summary

Fat composition of the spinal tumors is positively correlated with classification and differential diagnosis of benign and malignant tumors.

Conditions

  • Spinal Tumor
  • Bone Tumor

Interventions

DIAGNOSTIC_TEST

Chemical shift encoding-based water-fat MRI

Chemical shift encoding-based water-fat magnetic resonance imaging (MRI): a non-invasive method

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Ning Lang · Peking University Third Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2023-12-01
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05631002 on ClinicalTrials.gov